Detalhe da pesquisa
1.
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): a phase III, randomized, double-blind, placebo-controlled study.
Breast Cancer Res Treat
; 182(3): 689-697, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564260
2.
Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma.
Haematologica
; 102(4): 765-772, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011903
3.
Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study.
Blood
; 124(14): 2196-202, 2014 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25143487
4.
Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000).
Blood
; 122(7): 1137-43, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23843495
5.
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis.
Ann Rheum Dis
; 72(3): 329-36, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22689315
6.
BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis.
Clin Lymphoma Myeloma Leuk
; 21(4): 267-278.e10, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33303421
7.
IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis.
BMJ Open
; 3(8): e003199, 2013 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23959753
8.
Obinutuzumab (GA101) in patients with relapsed/refractory indolent non-Hodgkin lymphoma: results from the phase II GAUGUIN study.
J Clin Oncol
; 31(23): 2920-6, 2013 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23835715
9.
Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN study.
J Clin Oncol
; 31(23): 2912-9, 2013 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23835718
10.
Analysing time course microarray data using Bioconductor: a case study using yeast2 Affymetrix arrays.
BMC Res Notes
; 3: 81, 2010 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-20302631
11.
A genome wide analysis of the response to uncapped telomeres in budding yeast reveals a novel role for the NAD+ biosynthetic gene BNA2 in chromosome end protection.
Genome Biol
; 9(10): R146, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18828915